Q120 remained a bright spot showing positive growth with modest disruption from COVID-19 for the quarter.
For Q120, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market was up +4. 4% YoY. The prevention of Hospital-Acquired Infections (HAIs) continues to drive measures and practices to reduce Central Line-Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. Numerous programs and educational tools are being developed to provide measures and strategies that assist healthcare providers in the prevention and reduction of infection in acute care and other settings.Among the many topics covered in the comprehensive Q120 Infection Prevention: Vascular Access Adjunct Products Recap Market Recap* are:
- Complete Q120 Market Highlights
- Dressings: Securement and Stabilization of VA Devices
- Antimicrobial Devices Continue to Capture Share
- Antimicrobial IV Skin Preps
- Mechanical Securement Devices Solid Increase
- Q120 Patents and Other Market News
SmartTRAK believes the majority of companies in this market will experience a lower level of impact from COVID-19 since catheters are used in nearly all hospitalized patients across the system and not just for elective surgery. In addition, many hospitals have been stockpiling products to prevent shortages in response to COVID-19 in Q120. Manufacturers in this segment have stated they will be largely impacted by COVID-19 restrictions and declines in elective procedures during Q220 ...
Read the entire Q120 Infection Prevention: Vascular Access Adjunct Products Market Recap including news, data, charts, company revenues and analysis*
*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.
